Rothlein R, Czajkowski M, O'Neill M M, Marlin S D, Mainolfi E, Merluzzi V J
Department of Immunology, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877.
J Immunol. 1988 Sep 1;141(5):1665-9.
The expression of intercellular adhesion molecule-1 (ICAM-1) on primary human fibroblasts, a human fibrosarcoma, chondrosarcoma, and adenocarcinoma cell line in response to IL-1, TNF-alpha, or IFN-gamma was studied using an ELISA with anti-ICAM-1 mAb. The induction of ICAM-1 by these cytokines was neutralized by cytokine-specific antisera as well as some steroids and the glycosylation inhibitor, tunicamycin. Cyclohexamide up-regulated the expression of ICAM-1 on chondrosarcoma cells but had little or no effect on carcinoma cells. These data indicate different mechanisms in the regulation and expression of ICAM-1 on the various cell types and provide some insight into the anti-inflammatory effects of some pharmacologic agents.
使用抗细胞间黏附分子-1(ICAM-1)单克隆抗体的酶联免疫吸附测定法(ELISA),研究了原代人成纤维细胞、人纤维肉瘤、软骨肉瘤和腺癌细胞系中ICAM-1在白细胞介素-1(IL-1)、肿瘤坏死因子-α(TNF-α)或γ-干扰素(IFN-γ)作用下的表达情况。这些细胞因子对ICAM-1的诱导作用被细胞因子特异性抗血清以及某些类固醇和糖基化抑制剂衣霉素所中和。环己酰亚胺上调了软骨肉瘤细胞上ICAM-1的表达,但对癌细胞几乎没有影响或没有影响。这些数据表明,ICAM-1在不同细胞类型上的调节和表达机制不同,并为某些药理剂的抗炎作用提供了一些见解。